News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Initiation of Dosing Begins in Phase 1 Trial of VTX3232, an Innovative CNS-penetrant NLRP3 Inhibitor, by Ventyx Biosciences
Thursday, June 15, 2023Ventyx Biosciences Inc Nasdaq VTYX announced the initiation of a Phase clinical trial for their new drug candidate VTX The company aims to develop novel oral therapies to address inflammatory diseases with significant unmet medical needs VTX is a CN...
QuVa Pharma Strengthens RFID Capabilities for Pre-Tagged, Ready-to-Administer Injectables
Wednesday, June 14, 2023QuVa Pharma Inc has announced its plans to expand its RFID capabilities for pretagged injectable products The company will be incorporating RFID tags that adhere to GSs global standards ensuring interoperability and compatibility By adopting this ope...
Valo Therapeutics and Texcell Announce Collaboration to Evaluate Immune Responses to PeptiCRAd-1 in Phase I Clinical Study
Wednesday, June 14, 2023Valo Therapeutics Oy ValoTx a company specializing in the development of adaptable immunotherapies for cancer has announced a collaboration with Texcell a global contract research organization The partnership aims to investigate the immune responses...
Salipro Biotech Achieves Granted Patent in Japan, Strengthening Global Intellectual Property Portfolio
Tuesday, June 13, 2023Salipro Biotech AB a pioneering biotech company focused on the discovery of nextgeneration therapeutics targeting challenging drug targets is pleased to announce the issuance of a new patent in Japan for its Salipro platform technology This patent ti...
Phathom Pharmaceuticals' Nda Resubmission for Erosive Gerd Accepted by Fda
Tuesday, June 13, 2023Phathom Pharmaceuticals Inc has made an announcement regarding the progress of its New Drug Application NDA for vonoprazan a novel treatment for Erosive GERD gastroesophageal reflux disease The company received a complete response letter CRL from the...
Novartis Enhances Innovative Medicines Strategy and Renal Pipeline Through Chinook Therapeutics Acquisition for an Upfront Payment of Usd 3.2 Billion (Usd 40 Per Share)
Monday, June 12, 2023Novartis has recently announced its acquisition of Chinook Therapeutics a clinicalstage biopharmaceutical company based in Seattle The acquisition is in line with Novartis strategy to expand its renal portfolio and focus on innovative medicines Chino...
Novo Nordisk to Invest Dkk 15.9 Billion in Expanding Manufacturing Facilities in Hillerød, Denmark
Monday, June 12, 2023Novo Nordisk has recently announced a significant investment of billion Danish kroner to expand its existing Active Pharmaceutical Ingredient API production facility in Denmark This expansion aims to cater to the growing demand for medications in th...
Rocket Pharmaceuticals Granted Fda Fast Track and Orphan Drug Designations for Rp-a601 Gene Therapy in Pkp2 Arrhythmogenic Cardiomyopathy (Acm)
Friday, June 09, 2023Rocket Pharmaceuticals Inc NASDAQ RCKT has recently announced significant developments regarding their gene therapy candidate RPA for the treatment of plakophilin related arrhythmogenic cardiomyopathy PKPACM The US Food and Drug Administration FDA ha...
Pipeline Therapeutics Granted Fda Clearance to Begin Phase 1 Study of Pipe-791
Friday, June 09, 2023Pipeline Therapeutics has received clearance from the US Food and Drug Administration FDA to begin a Phase clinical trial of their drug candidate PIPE in healthy volunteers PIPE is a small molecule antagonist of the lysophosphatidic acid receptor L...
FDA Grants Fast Track Designation to SAR'579 / IPH6101 for the Treatment of Hematological Malignancies
Thursday, June 08, 2023Innate Pharma SA Euronext Paris IPH Nasdaq IPHA is pleased to announce that the US Food and Drug Administration FDA has granted Fast Track Designation for SARIPH a potential treatment for hematological malignancies Fast Track Designation is a process...
